Full details, including potential risk factors, are given in the Press Release, which can be consulted by clicking on the link below
Nicox is Granted Patent for Blepharitis Product Candidate NCX 4251 in Europe

November 17, 2021

View Press Release Corporate presentation Contact us
Previous